Clinical trial
Study of the Disease Process of Lymphangioleiomyomatosis
NCT00001465 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Recruiting
Key facts
| NCT number | NCT00001465 |
|---|---|
| Title | Study of the Disease Process of Lymphangioleiomyomatosis |
| Official title | Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Lung Disease, Pneumothorax, Tuberous Sclerosis, Lymphangioleiomyomatosis |
| Intervention type | Device |
| Interventions | Toshibia Aquilion One CT |
| Enrollment | 2,000 |
| Start date | Dec 18, 1995 |
| First posted | Nov 4, 1999 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: